首页> 外文期刊>Oncogene >Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex
【24h】

Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex

机译:Foxo3a转录因子是Skp2和Skp2 SCF复合体的负调控因子

获取原文
       

摘要

Skp2 (S-phase kinase-associated protein-2) SCF complex displays E3 ligase activity and oncogenic activity by regulating protein ubiquitination and degradation, in turn regulating cell cycle entry, senescence and tumorigenesis. The maintenance of the integrity of Skp2 SCF complex is critical for its E3 ligase activity. The Skp2 F-box protein is a rate-limiting step and key factor in this complex, which binds to its protein substrates and triggers ubiquitination and degradation of its substrates. Skp2 is found to be overexpressed in numerous human cancers, which has an important role in tumorigenesis. The molecular mechanism by which the function of Skp2 and Skp2 SCF complex is regulated remains largely unknown. Here we show that Foxo3a transcription factor is a novel and negative regulator of Skp2 SCF complex. Foxo3a is found to be a transcriptional repressor of Skp2 gene expression by directly binding to the Skp2 promoter, thereby inhibiting Skp2 protein expression. Surprisingly, we found for the first time that Foxo3a also displays a transcription-independent activity by directly interacting with Skp2 and disrupting Skp2 SCF complex formation, in turn inhibiting Skp2 SCF E3 ligase activity and promoting p27 stability. Finally, we show that the oncogenic activity of Skp2 is repressed by Foxo3a overexpression. Our results not only reveal novel insights into how Skp2 SCF complex is regulated, but also establish a new role for Foxo3a in tumor suppression through a transcription-dependent and independent manner.
机译:Skp2(S期激酶相关蛋白2)SCF复合物通过调节蛋白泛素化和降解,进而调节细胞周期进入,衰老和肿瘤发生,显示E3连接酶活性和致癌活性。 Skp2 SCF复合体的完整性维持对其E3连接酶活性至关重要。 Skp2 F-box蛋白是该复合物中的限速步骤和关键因素,该复合物与其蛋白底物结合并触发其底物的泛素化和降解。发现Skp2在许多人类癌症中过表达,这在肿瘤发生中具有重要作用。调节Skp2和Skp2 SCF复合物功能的分子机制仍然未知。在这里,我们显示Foxo3a转录因子是Skp2 SCF复合体的新型负调控因子。发现Foxo3a通过直接与Skp2启动子结合从而抑制Skp2蛋白表达,从而成为Skp2基因表达的转录抑制因子。令人惊讶的是,我们首次发现Foxo3a通过直接与Skp2相互作用并破坏Skp2 SCF复合物的形成,进而抑制Skp2 SCF E3连接酶的活性并促进p27的稳定性,也表现出转录独立的活性。最后,我们表明Foxo3a过表达抑制了Skp2的致癌活性。我们的结果不仅揭示了如何调控Skp2 SCF复合物的新颖见解,而且还通过转录依赖性和独立的方式确立了Foxo3a在肿瘤抑制中的新作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号